Renato Scalone

891 total citations
17 papers, 455 citations indexed

About

Renato Scalone is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Renato Scalone has authored 17 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Hematology and 6 papers in Genetics. Recurrent topics in Renato Scalone's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Renato Scalone is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Renato Scalone collaborates with scholars based in Italy. Renato Scalone's co-authors include Maurizio Musso, Alessandra Crescimanno, Ferdinando Porretto, Nicola Di Renzo, Emilio Iannitto, Giuliano Mariani, Stefano Luminari, Francesco Merli, Caterina Stelitano and Giulia Cervetti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancers.

In The Last Decade

Renato Scalone

15 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renato Scalone Italy 11 245 151 121 93 86 17 455
Guido Gini Italy 12 241 1.0× 210 1.4× 184 1.5× 59 0.6× 94 1.1× 37 629
Barbara Vannata Italy 12 347 1.4× 237 1.6× 71 0.6× 60 0.6× 72 0.8× 23 584
José C. Díaz‐Maqueo Mexico 12 261 1.1× 294 1.9× 98 0.8× 89 1.0× 52 0.6× 34 529
Ho Young Kim South Korea 11 98 0.4× 94 0.6× 97 0.8× 37 0.4× 86 1.0× 34 414
Joachim Bæch Denmark 10 163 0.7× 118 0.8× 115 1.0× 55 0.6× 46 0.5× 29 403
Jadwiga Małdyk Poland 12 267 1.1× 108 0.7× 51 0.4× 67 0.7× 111 1.3× 33 463
Lisa Downs United States 10 421 1.7× 158 1.0× 30 0.2× 178 1.9× 136 1.6× 23 605
Caroline Kuhlman United States 8 338 1.4× 301 2.0× 135 1.1× 65 0.7× 56 0.7× 12 596
E.‐W. Schwarze Germany 13 284 1.2× 124 0.8× 61 0.5× 89 1.0× 60 0.7× 37 470
Edna L. García Mexico 12 230 0.9× 287 1.9× 38 0.3× 63 0.7× 47 0.5× 29 473

Countries citing papers authored by Renato Scalone

Since Specialization
Citations

This map shows the geographic impact of Renato Scalone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Scalone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Scalone more than expected).

Fields of papers citing papers by Renato Scalone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Scalone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Scalone. The network helps show where Renato Scalone may publish in the future.

Co-authorship network of co-authors of Renato Scalone

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Scalone. A scholar is included among the top collaborators of Renato Scalone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Scalone. Renato Scalone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Filippi, Rosaria De, Gianpaolo Marcacci, Enrico Derenzini, et al.. (2022). Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study. Cancers. 14(23). 5846–5846. 3 indexed citations
3.
Merli, Francesco, Federica Cavallo, Flavia Salvi, et al.. (2019). Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. Journal of Geriatric Oncology. 11(1). 37–40. 15 indexed citations
4.
Musso, Maurizio, Giuseppe Messina, Gianpaolo Marcacci, et al.. (2015). High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients: A Phase II Study. Biology of Blood and Marrow Transplantation. 21(11). 1932–1938. 19 indexed citations
5.
6.
Musso, Maurizio, et al.. (2014). Allogeneic hematopoietic stem cell transplantation for aggressive lymphomas. 3(2). 73–73.
7.
Morabito, Fortunato, Stefan Hohaus, Corrado Mammì, et al.. (2011). Role of glutathione-s-transferase (gst) polymorphisms in patients with advanced hodgkin lymphoma: results from the hd2000 GISL trial. Leukemia & lymphoma. 53(3). 406–410. 3 indexed citations
8.
Musso, Maurizio, et al.. (2009). Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT. Bone Marrow Transplantation. 45(1). 123–127. 22 indexed citations
9.
Musso, Maurizio, Renato Scalone, Gianpaolo Marcacci, et al.. (2009). Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study. Bone Marrow Transplantation. 45(7). 1147–1153. 31 indexed citations
10.
Federico, Massimo, Stefano Luminari, Emilio Iannitto, et al.. (2009). ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. Journal of Clinical Oncology. 27(5). 805–811. 181 indexed citations
11.
Musso, Maurizio, et al.. (2008). Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy. Supportive Care in Cancer. 17(2). 205–209. 34 indexed citations
12.
13.
Musso, Maurizio, et al.. (2001). Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. American Journal of Hematology. 66(2). 75–79. 23 indexed citations
14.
Musso, Maurizio, et al.. (2000). Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant. Bone Marrow Transplantation. 26(8). 921–923. 31 indexed citations
15.
Musso, Maurizio, Ferdinando Porretto, Alessandra Crescimanno, et al.. (1999). Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation. Bone Marrow Transplantation. 24(2). 207–209. 10 indexed citations
16.
17.
Musso, Maurizio, Ferdinando Porretto, Alessandra Crescimanno, et al.. (1998). Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia.. PubMed. 82(5 Suppl). 4–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guido Gini Breakdown of academic impact, for papers by Barbara Vannata Breakdown of academic impact, for papers by José C. Díaz‐Maqueo Breakdown of academic impact, for papers by Ho Young Kim Breakdown of academic impact, for papers by Joachim Bæch Breakdown of academic impact, for papers by Jadwiga Małdyk Breakdown of academic impact, for papers by Lisa Downs Breakdown of academic impact, for papers by Caroline Kuhlman Breakdown of academic impact, for papers by E.‐W. Schwarze Breakdown of academic impact, for papers by Edna L. García
Rankless by CCL
2026